Clinical surveillance programs enable health systems to realize two significant benefits - improved patient care and increased revenue. Yet, cancer screening programs have received the lion’s share of attention from healthcare quality improvement advocates. Less attention is paid to surveillance programs that drive revenue while ensuring screened patients and those with actionable incidental findings identified elsewhere, receive appropriate follow-up.
This white paper highlights the opportunities around, and financial benefits of, implementing a patient follow-up and surveillance program.
1. The limitations of "Surveillance by Spreadsheet".
2. The new sources of revenue a surveillance program can generate.
3. The success factors that enable a surveillance program to provide a rapid return on investment.
